That is the problem with their communication. If we knew how much product, then I'm sure investors can make a more informed decision. I agree that Walmart could be better if Walmart pushed the OTC and the product by advertising. But if you read the tweet from the CEO of Walmart Health, she was raving about introducing a $100 OTC hearing aid. They'll like to push that. They aren't doing a third-party route because he (Justin) has blown too many capital raises and made too many pivots. Point in hand, when they were selling the most product, I think it was the buds; they were moving product and on a path to profitability, which would have enabled them to fund the hearing aid development. Now, that hindsight, which is 20:20 vision but its the reason they have to sell HP pros and Max to try and get funds to get them to OEM deals. A reasonably run company would have got 10 mill easily because they would have shown that they could sell the product. Many posters here said 10 mill was the minimum they needed in cash to get to sustainable profit long before the CR was announced. The biggest worry that has come out of this is whether the product is what the market wants. This may be the market rejecting the OTC product or the price point. Either way the only way out is gen 4 or bust.
NUH Price at posting:
13.0¢ Sentiment: Sell Disclosure: Held
(20min delay)